comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 23:02:09 - browse：61787

Sorrento Therapeutics — ARIANA DREHSLER/AFP via Getty Images

SAN DIEGO — U.S. legislation that seeks to restrict American biotechs from working with certain Chinese firms and suppliers is for now just that — a proposal, not a law. But the looming bill’s impact was clearly visible at this year’s meeting of the industry’s largest trade group.

A number of biotech companies in attendance at the meeting of the Biotechnology Innovation Organization told STAT they’re actively looking to strike deals with U.S.-based drug manufacturers rather than companies named in the legislation, even though doing so will be more costly. An executive at a U.S.-based contract development and manufacturing organization, or CDMO, who spoke on condition of anonymity, said that “month to month, new business has gone through the roof.”

Meanwhile, some Chinese suppliers not named in the bill are paradoxically drawing increased interest from biotechs — while hearing from some customers worried those manufacturers could be blacklisted in the future.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Ukraine and a new approach to mental health in war

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

STAT Virtual Event: Putting AI to the Test

Evacuations in place as 3 wildfires burn in eastern Washington state

Liz Cheney makes 1st public comment since Trump's election interference indictments

Experts study whether long Covid risk adds up with each reinfection

Majority of Americans think Trump's Ga. election interference case is serious: POLL

entertainment

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Walensky prepares to leave CDC — and Congress — behind

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Continuity nursing helped my family in our darkest PICU moments

How Vertex's cystic fibrosis drug is changing patients' lives

State Dept. review finds Biden bears some blame for Afghanistan failures

Lung cancer is America's deadliest cancer. Yet so few get screened

The cancer drug shortage isn’t new — and neither are the solutions

Hilary may become 1st tropical storm to make landfall in California in 84 years

Wildfire smoke exposes gaps in outdoor worker protections

The pain doctors face in trying to build their families

Wikipedia

Hilary expected to bring catastrophic, life

FDA approves first treatment for ultra

Second xenotransplant done with gene

Senators: Long

Changes to biosimilar regulatory framework must prioritize patients

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

entertainment

focus

focus

focus